This is a distressed liability management transaction that exchanges unsecured debt for secured debt, extending maturities but increasing secured leverage and reducing unsecured recovery prospects. Monitor the early tender date (likely late May 2026) for participation levels — if participation falls short of the 90%+ AHG commitment, the backstop parties may need to fund more new money, signaling weaker creditor support. The FY26E revenue decline of 5.5% and the large commercial payor loss (~$335-345M) are material headwinds; watch for further covenant tightening in the new RCF and potential rating actions on the new secured notes.
Price Chart
Executive Summary
Accendra Health entered into a comprehensive restructuring agreement with noteholders and lenders to exchange up to ~$1.03B of unsecured notes for new secured notes, raise $326.25M in new first-lien notes, and establish a $300M revolving credit facility. The transaction extends weighted average debt maturity from ~2.7 years to ~5.5 years and addresses near-term maturities, but reflects a distressed balance sheet with FY25A net leverage of 4.9x and a revenue decline of 5.5% projected for FY26E.
Key Facts
- Company entered Commitment Letter with holders of ~100% of 2029 Notes and ~83% of 2030 Notes to exchange existing unsecured notes for new secured first-lien (9.00%) and second-lien (9.75%) notes
- New money offering of $326.25M in First Lien Notes at par, with $261M backstopped by certain noteholders and a 3.50% cash fee to backstop parties
- Existing $450M revolver to be replaced with a new $300M revolver maturing 2030, subject to springing maturity provisions
- Proceeds from new money notes plus cash on hand (~$216M) will repay Term A-1 facility in full and pay down existing revolver
- FY25A Adjusted EBITDA was $375M on ~$2.8B revenue (post-P&HS divestiture); FY26E revenue projected at $2.61B (down 5.5% YoY) with Adjusted EBITDA of $345M
- Pro forma net leverage projected at 4.8x for FY26E and 4.4x for FY27E, with interest coverage of 2.4x and 2.3x respectively
- Weighted average debt maturity extends from ~2.7 years to ~5.5 years assuming 100% participation
- Company lost a large commercial payor contract representing ~$335-345M in annual revenue and ~$35-45M in EBITDA
- Term B-1 lenders consenting to waive mandatory prepayment on up to $400M of asset sale proceeds and to conform covenants
Financial Impact
Total debt exchange of ~$1.03B in unsecured notes for secured notes; $326.25M new money issuance; $116M debt reduction from exchange; $300M new revolver replacing $450M existing facility; FY25A Adj. EBITDA $375M; FY26E Adj. EBITDA projected at $345M
Risk Factors
- Revenue declining 5.5% in FY26E with Adjusted EBITDA falling from $375M to $345M
- Pro forma net leverage remains elevated at 4.8x in FY26E despite the restructuring
- Loss of large commercial payor contract (~$335-345M revenue) creates uncertainty in go-forward growth trajectory
- Exchange of unsecured notes for secured notes increases senior secured debt burden and reduces recovery for unsecured creditors
- Transaction is subject to multiple conditions including Required Senior Notes Consents (50.01% of each series) and may not close by June 30, 2026 deadline
- New RCF has springing maturity tied to outstanding Term B-1 loans and unsecured notes, creating refinancing risk if those are not addressed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-215654 |
| Document: d135857dex991.htm | 0001193125-26-215654 |
| Document: d135857d8k.htm | 0001193125-26-215654 |
| Document: 0001193125-26-215654-index-headers.html | 0001193125-26-215654 |
| Document: 0001193125-26-215654-index.html | 0001193125-26-215654 |
| Document: 0001193125-26-215654.txt | 0001193125-26-215654 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | 8-K | $0.3905 $0.2202 | ▲ +43.61% | ▲ +42.12% | $0.2053 (+47.43%) |
Oct 7, 2026 20d ago | SC 13G | $0.4729 $0.3128 | ▼ −33.85% | ▼ −32.87% | $0.2053 (−56.59%) |
Sep 17, 2026 5w ago | 8-K | $1.03 $0.7332 | ▼ −28.82% | ▼ −29.42% | $0.2053 (−80.07%) |
Aug 17, 2026 10w ago | 8-K | $1.07 $1.16 | ▲ +8.41% | ▲ +9.60% | $0.2053 (−80.81%) |
Aug 16, 2026 10w ago | Institutional Cluster | $1.07 $1.16 | ▲ +8.41% | ▲ +9.60% | $0.2053 (−80.81%) |
Aug 10, 2026 11w ago | 8-K | $1.26 $1.13 | ▼ −10.32% | ▼ −9.91% | $0.2053 (−83.71%) |
Aug 10, 2026 11w ago | 8-K | $1.40 $1.07 | ▲ +23.57% | ▲ +23.52% | $0.2053 (+85.34%) |
Aug 10, 2026 11w ago | 8-K | $1.40 $1.07 | ▼ −23.57% | ▼ −23.52% | $0.2053 (−85.34%) |
Jul 27, 2026 13w ago | EFFECT | $3.22 $3.41 | ▲ +5.90% | ▲ +3.39% | $0.2053 (−93.62%) |
Jun 25, 2026 17w ago | 8-K | $3.34 $3.59 | ▲ +7.49% | ▲ +5.32% | $0.2053 (−93.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers